Accrual to Clinical Trials (ACT)

The ACT Network is a real-time platform allowing researchers to explore and validate feasibility for clinical studies across the NCATS Clinical and Translational Science Award (CTSA) consortium, from their desktops. ACT helps researchers design and complete clinical studies, and is secure, HIPAA-compliant and IRB-approved.

ACT was developed collaboratively by members of NCATS’ Clinical and Translational Science Award (CTSA) consortium, with funding from the NIH National Center for Advancing Translational Sciences.

Publications based on research using the ACT Network must cite the UC Davis Clinical and Translational Science Center and the NCATS ACT grants using the following statement: “The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grants UL1TR001860 and UL1TR000005. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH."